<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Malignant Otitis Externa | Advanced Clinical Report</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link rel="stylesheet" href="stylesheet.css">
    
    <!-- Application Structure Plan:
         1. Thematic Dashboard: Moves away from a simple report to an "Expert System" layout.
         2. Critical Diagnostic Hub: Features the complete 7-point Levenson criteria.
         3. Multidimensional Staging: Compares Benecke and Chandler systems side-by-side.
         4. Advanced Management: Split into Medical (Pharmacology), Metabolic (Glycemic), and Adjunctive (HBOT/Surgery).
         5. Prognostic Analytics: Visualizes survival rates relative to cranial nerve involvement.
    -->

    <!-- Visualization & Content Choices:
         1. Goal: Compare Staging -> Viz: Side-by-Side Detail Cards (Grid).
         2. Goal: Management Flow -> Viz: Interactive Tabbed Protocol (Medical vs Surgical vs HBO).
         3. Goal: Prognosis -> Viz: Survival Curve (Chart.js Line Chart).
         4. Goal: Diagnostic Criteria -> Viz: Status-Indicated Checklist (7 Points).
    -->
</head>
<body class="text-slate-800">

    <div class="flex flex-col md:flex-row min-h-screen">
        
        <!-- Sidebar Navigation -->
        <nav class="w-full md:w-64 bg-slate-900 text-slate-300 flex-shrink-0 sticky top-0 md:h-screen overflow-y-auto z-50">
            <div class="p-6 border-b border-slate-700">
                <h1 class="text-xl font-bold text-teal-400">Malignant Otitis Externa<br><span class="text-white text-lg font-light">Masterclass</span></h1>
                <p class="text-xs mt-2 text-slate-400">For Medical Professionals</p>
            </div>
            <ul class="py-4 space-y-1">
                <li><button onclick="scrollToSection('overview')" class="nav-item w-full text-left px-6 py-3 hover:bg-slate-800 transition-colors flex items-center gap-3 active"><i class="fas fa-microscope w-5"></i> Overview & Epi</button></li>
                <li><button onclick="scrollToSection('pathology')" class="nav-item w-full text-left px-6 py-3 hover:bg-slate-800 transition-colors flex items-center gap-3"><i class="fas fa-dna w-5"></i> Pathophysiology</button></li>
                <li><button onclick="scrollToSection('diagnosis')" class="nav-item w-full text-left px-6 py-3 hover:bg-slate-800 transition-colors flex items-center gap-3"><i class="fas fa-user-md w-5"></i> Diagnosis</button></li>
                <li><button onclick="scrollToSection('staging')" class="nav-item w-full text-left px-6 py-3 hover:bg-slate-800 transition-colors flex items-center gap-3"><i class="fas fa-layer-group w-5"></i> Staging</button></li>
                <li><button onclick="scrollToSection('management')" class="nav-item w-full text-left px-6 py-3 hover:bg-slate-800 transition-colors flex items-center gap-3"><i class="fas fa-procedures w-5"></i> Management</button></li>
                <li><button onclick="scrollToSection('prognosis')" class="nav-item w-full text-left px-6 py-3 hover:bg-slate-800 transition-colors flex items-center gap-3"><i class="fas fa-chart-line w-5"></i> Prognosis</button></li>
            </ul>
        </nav>

        <!-- Main Content -->
        <main class="flex-1 p-4 md:p-8 lg:p-12 overflow-y-auto h-screen scroll-smooth" id="main-content">
            
            <!-- Hero Header -->
            <header class="mb-12 border-b pb-6 border-slate-200">
                <div class="flex items-start justify-between">
                    <div>
                        <a href="index.html" class="text-teal-600 hover:text-teal-800 text-sm inline-block mb-2">&larr; Back to Home</a>
                        <h2 class="text-3xl md:text-4xl font-bold text-slate-900 mb-2">Malignant Otitis Externa</h2>
                        <p class="text-xl text-teal-700 font-medium italic">"Skull Base Osteomyelitis"</p>
                    </div>
                    <div class="hidden md:block text-right">
                        <span class="bg-teal-100 text-teal-800 text-xs font-semibold px-2.5 py-0.5 rounded border border-teal-400">Diabetic Complication</span>
                        <p class="text-sm text-slate-500 mt-1">Pseudomonas aeruginosa</p>
                    </div>
                </div>
                <div class="mt-6 bg-blue-50 border-l-4 border-blue-500 p-4 rounded-r shadow-sm">
                    <p class="text-sm md:text-base text-blue-900">
                        <strong>Faculty Note:</strong> Malignant Otitis Externa (MOE) is a rare but serious progressive skull base osteomyelitis predominantly affecting elderly diabetics with poor glycemic control. Unlike simple external otitis, MOE requires extended systemic antibiotic therapy (often 6-12 weeks), rigorous glycemic optimization, and close radiologic monitoring. Early recognition and aggressive management are critical to prevent intracranial extension, multiple cranial nerve palsies, and death.
                    </p>
                </div>
            </header>

            <!-- SECTION 1: OVERVIEW & EPIDEMIOLOGY -->
            <section id="overview" class="mb-16 scroll-mt-8">
                <h3 class="text-2xl font-bold text-slate-800 mb-6 flex items-center gap-2">
                    <span class="bg-slate-800 text-white w-8 h-8 rounded flex items-center justify-center text-sm">1</span> 
                    Epidemiology & Demographics
                </h3>
                
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                    <!-- Text Content -->
                    <div class="space-y-4">
                        <div class="bg-white p-6 rounded-lg shadow-sm border border-slate-100">
                            <h4 class="font-bold text-lg text-teal-700 mb-3">Key Characteristics</h4>
                            <ul class="space-y-3 text-slate-600 list-disc list-inside">
                                <li><strong>Incidence:</strong> Rare disease. True incidence varies by study, estimated <0.01 per 100,000 in general population.</li>
                                <li><strong>Age:</strong> Predominantly affects elderly (>50 years), with peak incidence in 5th-7th decades.</li>
                                <li><strong>Gender:</strong> Equal gender distribution or slight male predominance.</li>
                                <li><strong>Risk Factors:</strong> Diabetes mellitus (>90% of cases), immunocompromised states, prior radiation to skull base.</li>
                                <li><strong>Epidemiology:</strong> MOE represents <5% of otitis externa cases but >90% of skull base osteomyelitis cases in diabetics.</li>
                            </ul>
                        </div>
                        <div class="bg-white p-6 rounded-lg shadow-sm border border-slate-100">
                            <h4 class="font-bold text-lg text-teal-700 mb-3">Clinical Presentation</h4>
                            <div class="grid grid-cols-3 gap-2 text-center">
                                <div class="p-3 bg-slate-50 rounded">
                                    <i class="fas fa-head-side-cough text-2xl text-red-400 mb-2"></i>
                                    <p class="text-sm font-semibold">Severe Otalgia</p>
                                </div>
                                <div class="p-3 bg-slate-50 rounded">
                                    <i class="fas fa-tint text-2xl text-red-600 mb-2"></i>
                                    <p class="text-sm font-semibold">Otorrhea</p>
                                </div>
                                <div class="p-3 bg-slate-50 rounded">
                                    <i class="fas fa-deaf text-2xl text-slate-400 mb-2"></i>
                                    <p class="text-sm font-semibold">Conductive Hearing Loss</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <!-- Chart Container -->
                    <div class="bg-white p-6 rounded-lg shadow-sm border border-slate-100">
                        <h4 class="font-bold text-slate-700 mb-2 text-center">Microbiology Distribution</h4>
                        <p class="text-xs text-slate-500 text-center mb-4">Pseudomonas aeruginosa is the predominant pathogen.</p>
                        <div class="chart-container">
                            <canvas id="organismChart"></canvas>
                        </div>
                    </div>
                </div>
            </section>

            <!-- SECTION 2: PATHOPHYSIOLOGY -->
            <section id="pathology" class="mb-16 scroll-mt-8">
                <h3 class="text-2xl font-bold text-slate-800 mb-6 flex items-center gap-2">
                    <span class="bg-slate-800 text-white w-8 h-8 rounded flex items-center justify-center text-sm">2</span> 
                    Pathophysiology
                </h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                    <!-- Text Content -->
                    <div class="space-y-4">
                        <div class="bg-white p-6 rounded-lg shadow-sm border border-slate-100">
                            <h4 class="font-bold text-lg text-teal-700 mb-3">Diabetic Microenvironment</h4>
                            <p class="text-slate-600 leading-relaxed mb-4">
                                MOE is not merely an external ear infection; it is a <strong>progressive skull base osteomyelitis</strong> of the temporal bone. The disease exploits multiple diabetic complications: impaired glucose homeostasis, microangiopathy (reducing bone perfusion), and neutrophil dysfunction (reducing inflammatory response). These deficiencies create an immunologic environment where the external auditory canal becomes a nidus for invasive infection through anatomical weaknesses.
                            </p>
                            <div class="grid grid-cols-1 md:grid-cols-3 gap-4">
                                <div class="p-4 bg-slate-50 rounded-xl border border-slate-100">
                                    <span class="text-xs font-bold text-blue-600 uppercase">Step 1</span>
                                    <p class="text-sm font-semibold mt-1">EAC Colonization</p>
                                    <p class="text-xs text-slate-500 mt-1">Pseudomonas aeruginosa preferentially colonizes the alkaline cerumen of diabetics, evading the normal acidic microenvironment.</p>
                                </div>
                                <div class="p-4 bg-slate-50 rounded-xl border border-slate-100">
                                    <span class="text-xs font-bold text-blue-600 uppercase">Step 2</span>
                                    <p class="text-sm font-semibold mt-1">Soft Tissue Penetration</p>
                                    <p class="text-xs text-slate-500 mt-1">Bacteria penetrate through the bony-cartilaginous junction and Fissures of Santorini into periosteal tissues.</p>
                                </div>
                                <div class="p-4 bg-slate-50 rounded-xl border border-slate-100">
                                    <span class="text-xs font-bold text-blue-600 uppercase">Step 3</span>
                                    <p class="text-sm font-semibold mt-1">Osteomyelitis</p>
                                    <p class="text-xs text-slate-500 mt-1">Chronic, indolent osteomyelitis with progressive bone resorption via parosteal and endosteal pathways, eventually extending to skull base.</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <!-- Chart Container -->
                    <div class="bg-white p-6 rounded-lg shadow-sm border border-slate-100">
                        <h4 class="font-bold text-slate-700 mb-2 text-center">Organism Profile</h4>
                        <p class="text-xs text-slate-500 text-center mb-4">Pseudomonas aeruginosa dominates in MOE.</p>
                        <div class="chart-container">
                            <canvas id="organismChart"></canvas>
                        </div>
                    </div>
                </div>
                <div class="bg-white p-6 rounded-lg shadow-sm border border-slate-100 border-l-4 border-l-orange-500">
                    <h4 class="font-bold text-lg text-orange-700 mb-3">Natural History Without Treatment</h4>
                    <p class="text-slate-600 text-sm">MOE is characterized by <strong>unrelenting, severe otalgia</strong> that persists despite standard topical antibiotic therapy and may not correlate with clinical exam findings. Untreated disease follows an indolent course over weeks to months, with potential for rapid deterioration and spread to intracranial structures. Mortality in untreated cases can exceed 50% in diabetic patients.</p>
                </div>
            </div>
        </section>

        <!-- SECTION 3: DIAGNOSIS -->
        <section id="diagnosis" class="mb-16 scroll-mt-8">
            <h3 class="text-2xl font-bold text-slate-800 mb-6 flex items-center gap-2">
                <span class="bg-slate-800 text-white w-8 h-8 rounded flex items-center justify-center text-sm">3</span> 
                Diagnosis
            </h3>
            <div class="text-center mb-8">
                <h4 class="text-2xl font-bold text-slate-900">The 7 Levenson's Diagnostic Criteria</h4>
                <p class="text-slate-500 mt-2">The academic gold standard for definitive diagnosis.</p>
            </div>
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-4">
                <!-- 1 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-crimson-700">
                    <div class="text-2xl mb-2">üëÇ</div>
                    <h4 class="font-bold text-sm">Pain (Otalgia)</h4>
                    <p class="text-xs text-slate-500 mt-1">Severe, deep-seated, often nocturnal and out of proportion.</p>
                </div>
                <!-- 2 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-crimson-700">
                    <div class="text-2xl mb-2">üíß</div>
                    <h4 class="font-bold text-sm">Otorrhea</h4>
                    <p class="text-xs text-slate-500 mt-1">Chronic, purulent discharge, often foul-smelling.</p>
                </div>
                <!-- 3 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-crimson-700">
                    <div class="text-2xl mb-2">üå±</div>
                    <h4 class="font-bold text-sm">Granulation Tissue</h4>
                    <p class="text-xs text-slate-500 mt-1">Found at bony-cartilaginous junction of EAC floor.</p>
                </div>
                <!-- 4 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-crimson-700">
                    <div class="text-2xl mb-2">‚ùå</div>
                    <h4 class="font-bold text-sm">Treatment Failure</h4>
                    <p class="text-xs text-slate-500 mt-1">Refractory to standard local therapy for > 1 week.</p>
                </div>
                <!-- 5 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-blue-500">
                    <div class="text-2xl mb-2">üç¨</div>
                    <h4 class="font-bold text-sm">Host Factors</h4>
                    <p class="text-xs text-slate-500 mt-1">Diabetes mellitus or an immunocompromised state.</p>
                </div>
                <!-- 6 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-blue-500">
                    <div class="text-2xl mb-2">üî¨</div>
                    <h4 class="font-bold text-sm">Microbiology</h4>
                    <p class="text-xs text-slate-500 mt-1">Positive culture for Pseudomonas aeruginosa (typically).</p>
                </div>
                <!-- 7 -->
                <div class="criteria-box p-6 bg-white rounded-xl shadow-sm border-l-4 border-emerald-500 lg:col-span-2">
                    <div class="text-2xl mb-2">‚ò¢Ô∏è</div>
                    <h4 class="font-bold text-sm">Positive Tc-99m Scan</h4>
                    <p class="text-xs text-slate-500 mt-1">Uptake in the temporal bone demonstrating active osteoblastic activity (Skull Base Osteomyelitis).</p>
                </div>
            </div>

            <div class="mt-8 grid grid-cols-1 lg:grid-cols-2 gap-6">
                <div class="p-4 bg-slate-100 rounded text-sm text-slate-700">
                    <h4 class="font-bold text-slate-800 mb-3">Imaging Studies</h4>
                    <ul class="space-y-2">
                        <li><strong>CT Temporal Bone:</strong> Essential for detecting bony erosion, particularly of the mastoid cortex, skull base, and petrous apex. Specificity ~90%.</li>
                        <li><strong>MRI:</strong> Gold standard for assessing soft tissue extension, dural involvement, and staging. T1 with gadolinium shows enhancement of inflamed periosteal tissues.</li>
                        <li><strong>Gallium-67 or Indium-111 Scintigraphy:</strong> Highly sensitive (>90%) for detecting active osteomyelitis. Serial scans used for monitoring treatment response. Normalization of scan indicates biological cure.</li>
                    </ul>
                </div>
                <div class="p-4 bg-slate-100 rounded text-sm text-slate-700">
                    <h4 class="font-bold text-slate-800 mb-3">Laboratory & Clinical Assessment</h4>
                    <ul class="space-y-2">
                        <li><strong>Inflammatory Markers:</strong> Baseline ESR and CRP; lack of elevation does NOT exclude MOE. Serial measurements guide treatment duration.</li>
                        <li><strong>Glycemic Control:</strong> HbA1c and blood glucose levels. Tight glycemic control is essential for cure.</li>
                        <li><strong>Culture:</strong> EAC drainage or biopsy specimen. Gram-negative rods (Pseudomonas) in >90% of cases.</li>
                        <li><strong>Cranial Nerve Assessment:</strong> Formal testing for CN VII, IX, X, XII palsies. Prognostically significant if present.</li>
                    </ul>
                </div>
            </div>
        </section>

        <!-- SECTION 4: STAGING -->
        <section id="staging" class="mb-16 scroll-mt-8">
            <h3 class="text-2xl font-bold text-slate-800 mb-6 flex items-center gap-2">
                <span class="bg-slate-800 text-white w-8 h-8 rounded flex items-center justify-center text-sm">4</span> 
                Staging Systems
            </h3>
            <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                <div class="bg-white p-6 rounded-2xl shadow-sm border border-slate-200">
                    <h3 class="text-xl font-bold text-slate-800 mb-4 flex items-center">
                        <span class="p-2 bg-blue-100 rounded-lg mr-3 text-blue-600">C</span> Chandler Staging System
                    </h3>
                    <div class="space-y-3">
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-blue-600">Stage I:</span> EAC & Soft Tissue only.</div>
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-blue-600">Stage II:</span> Bone involvement (Osteitis).</div>
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-blue-600">Stage III:</span> Extension to Parotid, Mastoid, or Infratemporal Fossa.</div>
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-blue-600">Stage IV:</span> Cranial Nerve palsy or Intracranial extension.</div>
                    </div>
                </div>
                <div class="bg-white p-6 rounded-2xl shadow-sm border border-slate-200">
                    <h3 class="text-xl font-bold text-slate-800 mb-4 flex items-center">
                        <span class="p-2 bg-emerald-100 rounded-lg mr-3 text-emerald-600">B</span> Benecke Classification
                    </h3>
                    <div class="space-y-3">
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-emerald-600">Grade 1:</span> Soft tissue infection (EAC/Parotid).</div>
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-emerald-600">Grade 2:</span> Skull base osteomyelitis (Limited).</div>
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-emerald-600">Grade 3:</span> Skull base osteomyelitis (Extensive + CN Palsy).</div>
                        <div class="p-3 bg-slate-50 rounded-lg"><span class="font-bold text-emerald-600">Grade 4:</span> Intracranial complications (Meningitis/Abscess).</div>
                    </div>
                </div>
            </div>
        </section>

        <!-- SECTION 5: MANAGEMENT -->
        <section id="management" class="mb-16 scroll-mt-8">
            <h3 class="text-2xl font-bold text-slate-800 mb-6 flex items-center gap-2">
                <span class="bg-slate-800 text-white w-8 h-8 rounded flex items-center justify-center text-sm">5</span> 
                Management Algorithm
            </h3>
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6">
                <!-- Column 1: Medical -->
                <div class="bg-white p-6 rounded-2xl shadow-sm border-t-4 border-blue-600">
                    <h3 class="font-bold text-lg mb-4">1. Antimicrobial Strategy</h3>
                    <div class="space-y-4">
                        <div class="p-4 bg-blue-50 rounded-xl">
                            <h4 class="font-bold text-sm text-blue-800">First-Line Agent</h4>
                            <p class="text-xs mt-1"><strong>Fluoroquinolone (Ciprofloxacin)</strong>: 750 mg PO BID or 400 mg IV q8-12h. Excellent bone penetration, high intracellular bioavailability. Treatment duration: 4-6 weeks minimum, often extended to 8-12 weeks depending on clinical response and imaging findings.</p>
                        </div>
                        <div class="p-4 bg-slate-50 rounded-xl">
                            <h4 class="font-bold text-sm text-slate-800">Severe/Resistant Cases</h4>
                            <p class="text-xs mt-1"><strong>Anti-pseudomonal Agents:</strong> Ceftazidime (2g IV q8h), Piperacillin-tazobactam (4.5g IV q6-8h), or Aminoglycosides (Tobramycin or Amikacin) + Fluoroquinolone. Higher-dose therapy needed for poor glycemic control or CNS involvement.</p>
                        </div>
                        <div class="p-4 bg-rose-50 rounded-xl">
                            <h4 class="font-bold text-sm text-rose-800">Fungal Infection (Aspergillus/Mucor)</h4>
                            <p class="text-xs mt-1"><strong>Voriconazole</strong> (IV then PO) or <strong>Amphotericin B</strong> (liposomal preferred) for culture-confirmed fungal MOE. Rare but seen in severely immunocompromised or poorly controlled diabetics. Often requires longer treatment and often surgical debridement.</p>
                        </div>
                    </div>
                </div>
                <!-- Column 2: Metabolic & Adjunctive -->
                <div class="bg-white p-6 rounded-2xl shadow-sm border-t-4 border-emerald-600">
                    <h3 class="font-bold text-lg mb-4">2. Metabolic & HBOT</h3>
                    <div class="space-y-4">
                        <div class="p-4 bg-emerald-50 rounded-xl">
                            <h4 class="font-bold text-sm text-emerald-800">Glycemic Optimization</h4>
                            <p class="text-xs mt-1"><strong>ESSENTIAL component of therapy.</strong> Target HbA1c < 7%, ideally < 6.5% during active infection. Frequent glucose monitoring. MOE will NOT resolve with persistently elevated glucose levels‚Äîthis is a absolute requirement for cure, not optional adjunctive therapy.</p>
                        </div>
                        <div class="p-4 bg-slate-50 rounded-xl">
                            <h4 class="font-bold text-sm text-slate-800">Aural Toilet</h4>
                            <p class="text-xs mt-1">Regular otologic office debridement of granulation tissue and necrotic bone under direct visualization. Facilitates medication penetration and may provide culture material. Avoid aggressive instrumentation that risks exposing more bone to infection.</p>
                        </div>
                        <div class="p-4 bg-slate-900 text-white rounded-xl">
                            <h4 class="font-bold text-sm text-emerald-400">Hyperbaric Oxygen (HBOT)</h4>
                            <p class="text-xs mt-1">Controversial adjunctive therapy. Considered for Stage III/IV disease, recurrent cases, or cranial nerve involvement. Enhanced angiogenesis and osteoblast recruitment. Literature shows 70% cure rates in treated cohorts, but unclear if benefit is independent of antibiotics alone.</p>
                        </div>
                    </div>
                </div>
                <!-- Column 3: Surgical indications -->
                <div class="bg-white p-6 rounded-2xl shadow-sm border-t-4 border-slate-900">
                    <h3 class="font-bold text-lg mb-4">3. Surgical Indications</h3>
                    <p class="text-xs text-slate-500 mb-4">Surgery is generally avoided (risk of exposing more bone to infection) except for:</p>
                    <ul class="space-y-2">
                        <li class="flex items-start text-sm bg-slate-50 p-2 rounded"><span class="text-red-500 mr-2">‚óè</span> <strong>Biopsy:</strong> When diagnosis is uncertain or to exclude SCC of EAC. Culture obtained from granulation tissue. Risk of hemorrhage must be weighed against diagnostic benefit.</li>
                        <li class="flex items-start text-sm bg-slate-50 p-2 rounded"><span class="text-red-500 mr-2">‚óè</span> <strong>Abscess Drainage/I&D:</strong> Only if frank collection detected (rare in MOE‚Äîusually just cellulitis). May be necessary in intracranial complications.</li>
                        <li class="flex items-start text-sm bg-slate-50 p-2 rounded"><span class="text-red-500 mr-2">‚óè</span> <strong>Sequestrectomy:</strong> Removal of sequestered bone fragments if disease progresses despite antibiotics. Rarely performed and controversial due to potential for further bone exposure.</li>
                    </ul>
                    <div class="mt-4 p-3 border border-red-200 bg-red-50 rounded-lg text-[10px] text-red-700">
                        <strong>‚ö†Ô∏è CRITICAL:</strong> Facial nerve decompression is contraindicated. CN VII palsy results from inflammatory edema and toxin-mediated injury, not mechanical compression. Surgery does not improve CN outcome and risks further complications.
                    </div>
                </div>
            </div>
        </section>

        <!-- SECTION 6: PROGNOSIS -->
        <section id="prognosis" class="mb-16 scroll-mt-8">
            <h3 class="text-2xl font-bold text-slate-800 mb-6 flex items-center gap-2">
                <span class="bg-slate-800 text-white w-8 h-8 rounded flex items-center justify-center text-sm">6</span> 
                Prognosis & Survival
            </h3>
            <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                <div class="bg-white p-8 rounded-2xl shadow-sm border border-slate-200">
                    <h3 class="text-xl font-bold mb-6">Survival & Clinical Variables</h3>
                    <div class="chart-container">
                        <canvas id="prognosisChart"></canvas>
                    </div>
                    <p class="text-xs text-slate-500 mt-4 italic">*Prognosis significantly worsens with each additional cranial nerve involved.</p>
                </div>
                <div class="bg-slate-900 text-white p-8 rounded-2xl shadow-xl">
                    <h3 class="text-xl font-bold mb-4">Monitoring Resolution</h3>
                    <div class="space-y-6">
                        <div>
                            <h4 class="text-blue-400 font-bold text-sm uppercase">ESR & CRP</h4>
                            <p class="text-xs text-slate-400 mt-1">Weekly tracking. Failure of ESR to fall suggests treatment resistance or non-compliance.</p>
                        </div>
                        <div>
                            <h4 class="text-blue-400 font-bold text-sm uppercase">Gallium-67 vs. Indium-111</h4>
                            <p class="text-xs text-slate-400 mt-1"><strong>Gallium-67</strong> accumulates in areas of inflammation via binding to transferrin and lactoferrin. More sensitive for detecting active osteomyelitis. <strong>Indium-111</strong> labels leukocytes directly‚Äîhigher specificity. Serial scans (baseline, 4-6 weeks, 12 weeks) guide treatment duration. Normalization indicates biological cure; treatment typically continues 1-2 weeks after scan normalization.</p>
                        </div>
                        <div class="border-t border-slate-800 pt-4">
                            <h4 class="text-rose-400 font-bold text-sm">Recurrence Rate</h4>
                            <div class="w-full bg-slate-800 rounded-full h-2.5 mt-2">
                                <div class="bg-rose-500 h-2.5 rounded-full" style="width: 25%"></div>
                            </div>
                            <p class="text-[10px] text-slate-500 mt-1">Approximately 5-15% recurrence with adequate treatment (6-12 weeks). Rates up to 25-30% if treatment <6 weeks. Requires glycemic control for cure.</p>
                        </div>
                    </div>
                </div>
            </div>

            <div class="mt-8 grid grid-cols-2 md:grid-cols-4 gap-4">
                <div class="bg-white p-4 rounded shadow-sm border-t-4 border-green-500 text-center">
                    <span class="block text-3xl font-bold text-slate-800">80-90%</span>
                    <span class="text-sm text-slate-500">Localized Disease (5-yr)</span>
                </div>
                <div class="bg-white p-4 rounded shadow-sm border-t-4 border-yellow-500 text-center">
                    <span class="block text-3xl font-bold text-slate-800">50-70%</span>
                    <span class="text-sm text-slate-500">Advanced Disease (5-yr)</span>
                </div>
                <div class="bg-white p-4 rounded shadow-sm border-t-4 border-orange-500 text-center">
                    <span class="block text-3xl font-bold text-slate-800">20-40%</span>
                    <span class="text-sm text-slate-500">Cranial Nerve Palsy (5-yr)</span>
                </div>
                <div class="bg-white p-4 rounded shadow-sm border-t-4 border-red-500 text-center">
                    <span class="block text-3xl font-bold text-slate-800">< 10%</span>
                    <span class="text-sm text-slate-500">Intracranial Extension (5-yr)</span>
                </div>
            </div>
            <div class="mt-4 p-3 bg-red-50 text-red-700 text-sm rounded border border-red-100">
                <strong>‚ö†Ô∏è Critical Note:</strong> Without treatment, mortality approaches 50% in diabetic patients. Mortality increases significantly with cranial nerve involvement (up to 90% if multiple CNs affected). Early diagnosis, aggressive systemic antibiotics, and tight glycemic control are essential to prevent progression to intracranial disease and death.
            </div>
        </section>

    </main>

            <footer class="text-center text-slate-400 text-sm py-8 border-t border-slate-200">
                <p>Generated for Medical Education Purposes ‚Ä¢ 2024</p>
                <p class="mt-1">Always refer to the latest NCCN/ESMO guidelines for clinical decision making.</p>
            </footer>

        </main>
    </div>

    <script>
        // --- 1. Navigation Logic ---
        function scrollToSection(id) {
            const element = document.getElementById(id);
            const mainContent = document.getElementById('main-content');
            
            // Adjust scroll position for sticky header
            const offsetTop = element.offsetTop - 20;
            
            mainContent.scrollTo({
                top: offsetTop,
                behavior: 'smooth'
            });

            // Update active state in nav
            document.querySelectorAll('.nav-item').forEach(btn => {
                btn.classList.remove('active');
                if(btn.innerHTML.includes(id)) {
                   btn.classList.add('active');
                }
            });
        }

        // Charts Implementation
        function initCharts() {
            // Microbiology
            const ctxOrg = document.getElementById('organismChart').getContext('2d');
            new Chart(ctxOrg, {
                type: 'doughnut',
                data: {
                    labels: ['P. Aeruginosa (95%)', 'S. Aureus (2%)', 'Proteus (1%)', 'Aspergillus (2%)'],
                    datasets: [{
                        data: [95, 2, 1, 2],
                        backgroundColor: ['#2563eb', '#94a3b8', '#cbd5e1', '#e11d48'],
                        borderWidth: 0
                    }]
                },
                options: {
                    maintainAspectRatio: false,
                    plugins: { legend: { position: 'bottom', labels: { boxWidth: 12, font: { size: 10 } } } }
                }
            });

            // Survival Prognosis Curve
            const ctxProg = document.getElementById('prognosisChart').getContext('2d');
            new Chart(ctxProg, {
                type: 'line',
                data: {
                    labels: ['No CN Palsy', 'CN VII Only', 'CN VII + IX', 'Multiple CNs', 'Intracranial'],
                    datasets: [{
                        label: 'Estimated Survival Rate (%)',
                        data: [95, 80, 60, 40, 15],
                        borderColor: '#2563eb',
                        backgroundColor: 'rgba(37, 99, 235, 0.1)',
                        fill: true,
                        tension: 0.4,
                        pointRadius: 6,
                        pointBackgroundColor: '#fff',
                        pointBorderWidth: 2
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: { beginAtZero: true, max: 100, ticks: { font: { size: 10 } } },
                        x: { ticks: { font: { size: 10 } } }
                    },
                    plugins: { legend: { display: false } }
                }
            });
        }

        window.onload = function() {
            initCharts();
        };
    </script>
</body>
</html>